Patient Education · Sleep & Medication
Coming off sleeping tablets: a safer, supervised roadmap
If a sleeping tablet has become part of every night, stopping is not simply a matter of throwing it away. Benzodiazepines and Z-drugs can produce physical dependence even when taken exactly as prescribed. A good taper is individual, flexible and paired with treatment for the insomnia or anxiety that remains.
Which Medicines
Benzodiazepines and Z-drugs
need particular care
Benzodiazepines and related Z-drugs can reduce arousal and help sleep in the short term. With regular use, the nervous system adapts. The same dose may feel less effective, missing a dose may produce symptoms, and stopping suddenly can cause a marked rebound in insomnia or anxiety.
Physical dependence is not the same as addiction. Dependence describes adaptation and withdrawal; addiction involves a wider pattern such as impaired control, compulsive use and continued use despite harm. Stigma makes people hide both, so a careful consultation begins without blame.
The Main Safety Rule
Do not stop abruptly
after regular use
NICE recommends slow, stepwise reduction for medicines associated with dependence and withdrawal, with the schedule adjusted to the person’s response. Abrupt cessation can produce severe anxiety, tremor, sweating, nausea, perceptual disturbance, confusion and, in some circumstances, seizures or delirium.
Risk depends on the medicine, dose, duration, other substances, medical history and previous withdrawal. This is why an online percentage schedule cannot safely replace a prescriber who knows what you take.
Step 1
First, review the whole picture
before reducing anything
The review confirms the exact tablet, formulation, dose, timing, duration, missed-dose effects and any early or extra doses. Alcohol, opioids, antihistamines, pregabalin or gabapentin, and other sedating medicines matter because combined effects can increase harm.
The clinician also reassesses why the tablet began. Chronic insomnia, panic, grief, pain, depression, restless legs, sleep apnoea and an irregular sleep schedule need different plans. Withdrawal is harder when the original condition has been left untreated.
Step 2
Agree on a flexible taper,
not a deadline
A taper usually uses small planned reductions followed by time to observe. Lower doses may require smaller reductions because each change can feel proportionally larger. NICE advises that published schedules be applied flexibly and that the next reduction can be delayed, made smaller, or sometimes reversed when distressing withdrawal symptoms emerge.
For some short-acting benzodiazepines, a clinician may consider switching to a longer-acting one; this is not automatically appropriate and requires dose conversion, interaction and liver-health judgement. Z-drugs and benzodiazepines are not interchangeable DIY substitutes.
Step 3
Know what withdrawal can look like
without assuming every symptom is it
Withdrawal often begins with rebound insomnia or anxiety but may include irritability, poor concentration, tremor, sweating, nausea, sensory sensitivity or altered perception. Symptoms that start rapidly after a reduction, feel qualitatively new, or are much more intense than the original problem make withdrawal more likely.
Medical illness, a return of the underlying condition, substance effects and sleep deprivation can look similar. Review appointments are therefore diagnostic, not merely permission to make the next cut.
Step 4
Treat sleep while the dose falls,
not after the taper fails
CBT-I is the main evidence-based treatment for chronic insomnia and can be introduced alongside a taper. It works on the sleep window, bed-sleep association, unhelpful predictions and relapse planning rather than offering generic “sleep hygiene” alone.
NICE advises against treating withdrawal with another dependence-forming medicine and suggests considering CBT support during benzodiazepine withdrawal. Relaxation can help arousal, but it is an adjunct rather than a substitute for a taper and full insomnia treatment. The site’s breathing and JPMR exercises are educational tools, not detoxification treatment.
Review & Setbacks
Pausing is information,
not failure
At each review, the plan should record the current dose, symptoms, sleep, functioning, alcohol or other sedatives, and the next decision. If complete withdrawal is too difficult, an initial goal of a lower stable dose with ongoing review may be safer and more realistic.
Online follow-up can work when identity, medication details and safety can be established and local emergency support is available. Examination, severe withdrawal, complex substance use, pregnancy, major medical illness or uncertainty about what was taken may require in-person or hospital assessment.
Care With Dr. Shaurya Garg
If this article
sounds familiar
Do not use this article to calculate a taper. Bring the strips, bottles or clear photographs of every medicine to an appointment and describe what happens when a dose is late or missed.
Dr Shaurya Garg offers sleep-focused psychiatric assessment and medication review online across India and in person in New Delhi.
Sources & Further Reading
· NICE NG215: safe withdrawal from benzodiazepines, Z-drugs and antidepressants
· American Academy of Sleep Medicine: behavioural and psychological treatment of chronic insomnia
Sources are provided for education and were reviewed on 28 July 2026. They do not replace individual clinical assessment.
Common Questions
Sleeping-pill tapering,
answered safely
Can I stop a sleeping tablet suddenly?
Not after regular use without medical advice. Benzodiazepine and Z-drug withdrawal can be severe, and abrupt stopping may be dangerous for some people.
How long should a taper take?
There is no safe universal duration. The medicine, dose, duration, previous withdrawal, health, other substances and response to reductions determine the pace.
Is dependence the same as addiction?
No. Physical dependence is nervous-system adaptation with withdrawal on reduction. Addiction is a broader pattern involving impaired control, compulsive use and continued use despite harm. They can coexist, but one does not prove the other.
Should every short-acting benzodiazepine be switched to diazepam?
No. A longer-acting switch is sometimes considered, but conversion, interactions, age, liver health and individual response matter. It is a clinical decision, not a mandatory step.
Can CBT-I help during tapering?
Yes. Treating the insomnia that remains is central to a sustainable plan. CBT-I is first-line treatment for chronic insomnia and can be coordinated with medication reduction.